跳至主要内容
临床试验/ISRCTN14510401
ISRCTN14510401进行中(未招募)未知

The effect of dietary bioactives on gut microbiome diversity - a pilot study

Quadram Institute0 个研究点目标入组 27 人开始时间: 2021年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Males and females aged 18 - 65 years old
  • 2. BMI between 18.5 and 35 kg/m²
  • 3. HbA1c below 42 mmol/mol
  • 4. Access to a personal smart mobile phone enabled with near field communication (NFC) technology (this technology allows contactless card payments)
  • 5. Living in an area which can receive a supermarket delivery

排除标准

  • 1. Smokers (or stopped smoking for less than 3 months)
  • 2. Having diabetes, defined as HbA1c =48 mmol/mol or pre-diabetes, defined as HbA1c 42 – 47 mmol/mol
  • 3. Prescribed and non-prescribed medications that may affect the outcome measures for this study e.g. statins, laxatives
  • 4. Dietary supplements judged to affect the study data unless the participant is willing to discontinue them 4 weeks before the start of the study and for the duration of the study
  • 5. Use of antibiotics in the 6 months prior to the study
  • 6. Regular/recent use of colonic irrigation or other bowel cleansing techniques
  • 7. Use of pre/probiotics or fermented foods such as Yakult, Kefir products, unless the participant is willing to discontinue use 4 weeks before the start of the study and for the duration of the study
  • 8. Bowel movements =3 times per week
  • 9. Gastrointestinal diseases (excluding hiatus hernia unless symptomatic or study intervention/procedure is contraindicated)
  • 10. History of inflamed bowel (ulcerative colitis, Crohn’s disease or diverticulitis)
  • 11. Immune-related conditions associated with altered microbiome – lupus, type 1 diabetes, multiple sclerosis, poorly controlled thyroid disorders (Greaves disease, Hashimoto’s disease), rheumatoid arthritis
  • 12. Parallel participation in another research project
  • 13. Unwillingness to adhere to the dietary guidelines for the study
  • 14. Participation in another research project which has involved blood sampling within the last 4 months unless the total amount of combined blood from both studies does not exceed 470 ml
  • 15. Has donated or intends to donate blood within 16 weeks prior to or during the study period
  • 16. Any person related to or living with any member of the study team
  • 17. Those who are part of the line management or supervisory structure of the Chief Investigator
  • 18. Lack of capacity to provide written informed consent
  • 19. Are pregnant or have been pregnant within the last 12 months
  • 20. Participants following a vegetarian or vegan diet, as restrictions to bioactive-rich foods (fruits and vegetables) during the study may be too limiting
  • 21. Clinical eligibility test results deemed by the CRF medical advisor to be indicative of a health problem which may compromise the well-being of the participant or which could affect the study outcome
  • 22. Being susceptible to food allergies and intolerances
  • 23. Active infection with COVID-19

研究者

发起方
Quadram Institute

相似试验